Le Lézard
Classified in: Health
Subjects: SVY, EXE, AVO

New U.S. Government Research Strongly Supports BPA Safety, Says American Chemistry Council


WASHINGTON, Feb. 23, 2018 /PRNewswire-USNewswire/ -- The U.S. government today released its Draft Report with results from the largest study ever conducted on bisphenol A (BPA). The results of the study, which is the key part of a multi-year in-depth research program, strongly support the safety of BPA. 

"The results of the CLARITY Core study once again demonstrate that BPA is safe at the very low levels to which people are typically exposed. This study is the largest study ever conducted on BPA, and the results indicate that BPA has very little potential to cause health effects even when people are exposed to it throughout their lives," said Steven G. Hentges, Ph.D., Polycarbonate/BPA Global Group of the American Chemistry Council (ACC).

"The CLARITY Core study is the capstone of an in-depth research program conducted by scientists with the U.S. Food and Drug Administration (FDA) to answer key scientific questions and resolve uncertainties about the safety of BPA. With the results of the CLARITY Core study now available, FDA has substantially achieved its goals," Hentges said. 

The Draft Report, issued by the U.S. National Toxicological Program (NTP), states the results of a 5+ year, multi-million dollar study conducted by scientists at FDA's National Center for Toxicological Research with funding from NTP. The Draft Report will next undergo an expert peer review, which will include a public meeting of the peer-review panel on April 26. The report will then be finalized, and the results are expected to be published in the scientific literature.

Earlier studies from FDA's research program demonstrated that BPA is rapidly eliminated from the body after exposure and is thus unlikely to cause health effects. The CLARITY Core study resoundingly confirms the absence of health effects at typical human exposure levels. In this study, laboratory animals were exposed to various doses of BPA from pregnancy, through early-life development, and continuing through their entire lifetime.

"We now look forward to updated safety conclusions from regulatory authorities worldwide who have been awaiting the study results. Based substantially on the compelling body of U.S. government research already available, government bodies around the world have clearly stated that BPA is safe as currently used in food contact materials," Hentges said. "The results of this extensive study again confirm those earlier safety scientific assessments and validate FDA's recent response to the question 'Is BPA safe?' and the agency's one word answer: 'Yes.'"

http://www.americanchemistry.com

The American Chemistry Council (ACC) represents the leading companies engaged in the business of chemistry. ACC members apply the science of chemistry to make innovative products and services that make people's lives better, healthier and safer. ACC is committed to improved environmental, health and safety performance through Responsible Care®; common sense advocacy designed to address major public policy issues; and health and environmental research and product testing. The business of chemistry is a $768 billion enterprise and a key element of the nation's economy. It is among the largest exporters in the nation, accounting for fourteen percent of all U.S. goods exports. Chemistry companies are among the largest investors in research and development. Safety and security have always been primary concerns of ACC members, and they have intensified their efforts, working closely with government agencies to improve security and to defend against any threat to the nation's critical infrastructure.

SOURCE American Chemistry Council


These press releases may also interest you

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...

17 mai 2024
The Honourable Seamus O'Regan Jr., Minister of Labour and Seniors, on behalf of the Honourable Mark Holland, Canada's Minister of Health, and the Honourable Tom Osborne, Newfoundland and Labrador's Minister of Health and Community Services will make...



News published on and distributed by: